Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.
October 3, 2022
September 28, 2022
September 27, 2022
October 3, 2022 6:08 PM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.